New polymers for drug delivery systems in orthopaedics: in vivo biocompatibility evaluation.

The use of biodegradable polymers for drug delivery systems excluded the need for a second operation to remove the carrier. However, the development of an avascular fibrous capsule, reducing drug release, has raised concern about these polymers in terms of tissue-implant reaction. Five novel polymers were evaluated in vivo after implantation in the rat dorsal subcutis and compared to the reference polycaprolactone (PCL). Poly(cyclohexyl-sebacate) (PCS), poly(L-lactide-b-1,5-dioxepan-2-one-b-L-lactide) (PLLA-PDXO-PLLA), two 3-hydroxybutyrate-co-3-hydroxyvalerate copolymers (D400G and D600G), and a poly(organo)phosphazene (POS-PheOEt:Imidazole) specimens were histologically evaluated in terms of the inflammatory tissue thickness and vascular density at 4 and 12 weeks from surgery. The highest values of inflammatory tissue thickness were observed in D600G (P < 0.01), PCS (P < 0.001) and PLLA-PDXO-PLLA (P < 0.001) at 4 weeks, while POP-PheOEt:Imidazole showed the lowest value of inflammatory tissue thickness (P < 0.05) at 12 weeks. D400G, D600G, PLLA-PDXO-PPLA and POP-PheOEt:Imidazole showed higher (P < 0.001) values of vascular density near the implants in comparison to PCL at 4 weeks. Finally, D400G and D600G increased their vessel densities while POP-PheOEt:Imidazole and the synthetic polyester PLLA-PDXO-PLLA presented similar vessel density values during experimental times. These different behaviours to improve neoangiogenesis without severe inflammatory tissue-responses could be further investigated with drugs in order to obtain time-programmable drug delivery systems for musculoskeletal therapy.

[1]  S. Perren,et al.  Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). , 1993, Journal of biomedical materials research.

[2]  R. Giardino,et al.  Natural and Synthetic Polyesters for Musculoskeletal Tissue Repair: Experimental in Vitro and in Vivo Evaluations , 2004, The International journal of artificial organs.

[3]  D. Hayward,et al.  The effect of processing on the properties of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymers , 2001 .

[4]  J. Anglen,et al.  Elution Characteristics of Tobramycin From Polycaprolactone in a Rabbit Model , 2001, Clinical orthopaedics and related research.

[5]  T. Vail,et al.  Pharmacokinetics of a Degradable Drug Delivery System in Bone , 1998, Clinical orthopaedics and related research.

[6]  S. Davis,et al.  The release of diazepam from poly(hydroxybutyrate-hydroxyvalerate) microspheres , 2002, Journal of Microencapsulation.

[7]  A. Göpferich,et al.  Biodegradable poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterials. , 2000, Biomaterials.

[8]  J. Calhoun,et al.  Experimental Osteomyelitis Treatment With Antibiotic-Impregnated Hydroxyapatite , 2002, Clinical orthopaedics and related research.

[9]  B. Tighe,et al.  Polymers for biodegradable medical devices. III. Polymerization and copolymerization of cyclic derivatives of tartronic acid. , 1987, Biomaterials.

[10]  F. Korkusuz,et al.  In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods , 2002, Journal of microencapsulation.

[11]  John Samuel,et al.  Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.

[12]  V. Hasırcı,et al.  Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release , 2001, Journal of biomaterials science. Polymer edition.

[13]  V. Hasırcı,et al.  Properties and drug release behaviour of poly(3-hydroxybutyric acid) and various poly(3-hydroxybutyrate-hydroxyvalerate) copolymer microcapsules. , 1995, Journal of microencapsulation.

[14]  F. Korkusuz,et al.  In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. , 2001, Biomaterials.

[15]  J W Eaton,et al.  Inflammatory responses to biomaterials. , 1995, American journal of clinical pathology.

[16]  Terumi Saito,et al.  In vivo and in vitro degradation of poly(3-hydroxybutyrate) in pat , 1991 .

[17]  S. W. Kim,et al.  Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil. , 2001, Bio-medical materials and engineering.

[18]  J. Calhoun,et al.  Treatment of Experimental Osteomyelitis With a Fibrin Sealant Antibiotic Implant , 2002, Clinical orthopaedics and related research.

[19]  A. Albertsson,et al.  Resorbable and highly elastic block copolymers from 1,5-dioxepan-2-one and L-lactide with controlled tensile properties and hydrophilicity. , 2002, Biomacromolecules.

[20]  Shen‐guo Wang,et al.  Biodegradable poly(L-lactide)-poly(ethylene glycol) multiblock copolymer: synthesis and evaluation of cell affinity. , 2003, Biomaterials.

[21]  D. Zaffe,et al.  A reabsorbable tubular chamber for the treatment of large diaphyseal bone defects. Experimental study in rabbits. , 1998, The International journal of artificial organs.

[22]  D. Wise,et al.  Antibiotic release from biodegradable PHBV microparticles. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Steven P Schwendeman,et al.  Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. , 2002, Critical reviews in therapeutic drug carrier systems.

[24]  Andrianov,et al.  Protein release from polyphosphazene matrices. , 1998, Advanced drug delivery reviews.

[25]  P. Caliceti,et al.  Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation. , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[26]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[27]  P. Caliceti,et al.  Polyorganophosphazene microspheres for drug release: polymer synthesis, microsphere preparation, in vitro and in vivo naproxen release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[28]  J. Anglen,et al.  Treatment of Osteomyelitis With Local Antibiotics Delivered Via Bioabsorbable Polymer , 2003, Clinical orthopaedics and related research.

[29]  B. Tighe,et al.  Polymers for biodegradable medical devices. II. Hydroxybutyrate-hydroxyvalerate copolymers: hydrolytic degradation studies. , 1987, Biomaterials.

[30]  N. Özer,et al.  Poly(hydroxybutyrate-co-hydroxyvalerate) nanocapsules as enzyme carriers for cancer therapy: an in vitro study , 2002, Journal of microencapsulation.

[31]  F. Korkusuz,et al.  Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. , 1999, Journal of biomedical materials research.

[32]  R. Weusthuis,et al.  Properties, modifications and applications of biopolyesters. , 2001, Advances in biochemical engineering/biotechnology.

[33]  M Fini,et al.  Tailoring Biomaterial Compatibility: In Vivo Tissue Response versus in Vitro Cell Behavior , 2003, The International journal of artificial organs.